EDGAR Filing Documents for 0001564590-16-022811

Form 8-K - Current report:

SEC Accession No. 0001564590-16-022811

Filing Date

2016-08-05

Accepted

2016-08-04 20:39:10

Documents

Period of Report

2016-08-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	apvo-8k_20160804.htm	8-K	38631
2	EX-10.1	apvo-ex101_7.htm	EX-10.1	1610910
3	EX-10.2	apvo-ex102_6.htm	EX-10.2	29310
4	GRAPHIC	gjeypdz4t4pk000001.jpg	GRAPHIC	3344
5	GRAPHIC	g03imm3m4qzs000001.jpg	GRAPHIC	2913
	Complete submission text file	0001564590-16-022811.txt		1689038

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121

Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500

Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)